IPCALAB - Ipca Laboratories

Ipca Laboratories

IPCALAB · Pharma > Pharmaceuticals & Drugs · Chairman: Premchand Godha · MD: Premchand Godha · Listing date: Oct. 24, 1994 · Employees: 14574 · Mumbai · http://www.ipca.com

Stock Price vs Company Growth

2.4%

0.0%

5.0%

12.9%

19.8%

3.1%

12.8%

10y

15.5%

all

19.6%

🤔 How to analyze this graph?

Last Traded Price

₹ 1,364 2.4%

1,200

1,599

Company Overview

Sales

8,726 Cr

Growth: 20.4%

Profit after Tax

729 Cr

Growth: 23.1%

Large Cap

34,607 Cr

P/E: 47.4x

Industry P/E: 29.6x

Fundamentals

Sales (Cr)	₹ 8,726
Growth	20.4%
EBITDA	18.6%
P/S	4.0x
Dividend	0.3%
P/E	47.4x
Book Value	₹ 276
PEG Ratio	2.3x
ROE	11.0%
P/B	4.9x

Shareholding Pattern

Institutions

Dsp Midcap Fund

4.58 %

Hdfc Trustee Company Ltd - A/C Hdfc Mid - Capopportunities Fund

3.1 %

L And T Mutual Fund Trustee Ltd-L And T Mid Cap Fund

2.32 %

Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund

2.19 %

Hdfc Life Insurance Company Limited

2.02 %

Promoters

Kaygee Investments Pvt. Ltd.

21.47 %

Kaygee Laboratories Pvt. Ltd.

6.61 %

Chandurkar Investments Pvt. Ltd.

5.5 %

Paschim Chemicals Pvt. Ltd.

4.0 %

Premchand Godha

2.29 %

Others

Iepf

0.29 %

Llp

0.02 %

Increase Decrease No change

Company Profile Detailed

Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Services and productsAPI- Ipca produces various APIs at its production facilities. Its core strategic focus has been on backward integration, resulting in superior supply chain reliability and cost competitiveness in a dynamic market. Ipca has also emerged as one of India’s top exporters of APIs, serving in many countries around the globe.

Belongs to (27 Indices) view more

Investors (99)

dr.kaila...

mexin.me...

icici.pr...

Followers (11)

keerthi

nitin2

deepak